Search Tag: Neuro-oncology

IT Management

2025 18 Nov

  Cancers of the central nervous system (CNS) remain difficult to treat and insufficiently understood, with high morbidity and mortality. Artificial intelligence is moving into the neuro-oncological pathway, spanning prevention, diagnosis, treatment, prognostication and rehabilitation. Reported uses include image analysis, molecular characterisation,...Read more

IMAGING Management

2025 18 Nov

  Cancers of the central nervous system (CNS) remain difficult to treat and insufficiently understood, with high morbidity and mortality. Artificial intelligence is moving into the neuro-oncological pathway, spanning prevention, diagnosis, treatment, prognostication and rehabilitation. Reported uses include image analysis, molecular characterisation,...Read more

Artificial Intelligence

2025 18 Nov

  Cancers of the central nervous system (CNS) remain difficult to treat and insufficiently understood, with high morbidity and mortality. Artificial intelligence is moving into the neuro-oncological pathway, spanning prevention, diagnosis, treatment, prognostication and rehabilitation. Reported uses include image analysis, molecular characterisation,...Read more

IMAGING Management

2025 09 Apr

Radiomics has emerged as a transformative tool in neuro-oncology, offering a noninvasive means to quantify tumour characteristics and support clinical decisions. Through computational analysis of imaging data, radiomics enables detailed insight into tumour biology, enhancing diagnostic precision, prognostication, treatment planning and monitoring....Read more

IMAGING Management

2024 27 Oct

  Brain imaging is critical in diagnosing neurological, psychiatric and neuro-oncological disorders. Among the techniques available, 2-[ 18 F]fluoro-2-deoxy-D-glucose ([ 18 F]FDG) PET imaging stands out for its ability to map regional glucose metabolism, which is a key indicator of neuronal activity. The updated guidelines by the Society of Nuclear...Read more

IMAGING Management

2024 25 Aug

  High-grade gliomas (HGGs) are aggressive brain tumours with a grim prognosis, even with advancements in cancer treatment. Monitoring the progression of these tumours is crucial for effective patient management, but conventional MRI techniques often struggle to distinguish between tumour progression and treatment effects. Advanced MRI-based neuroimaging,...Read more